Sandra and Edward Meyer Cancer Center

News

2017 Aug 24

Precision medicine in hematologic malignancies

John P. Leonard, M.D., discusses the advance of precision medicine across hematologic malignancies. Read more

David Nanus, M.D., discusses cancer drug prices

2017 Aug 24

Early stage kidney cancer treatment

David M. Nanus, M.D., discusses treatment for patients with early-stage kidney cancer. Read more

2017 Aug 23

A million dollars in Movember money funds advanced prostate cancer research

Meyer prostate cancer experts led by Scott Tagawa, M.D., will use Movember funds to investigate a new treatment for an advanced form of the disease. Read more

Howard Fine, M.D., is creating 'mini brains' in his lab at Meyer Cancer Center

2017 Aug 23

Research trial in NYC may change course of brain tumor treatment

Howard Fine, M.D., is determined to change the course of glioblastoma treatment, by testing drugs on 'mini brains' created in the lab. Read more

2017 Aug 18

Potential of immunotherapy in MCL landscape

Peter Martin, M.D., discusses the potential of modern immunotherapies in the landscape of mantle cell lymphoma (MCL). Read more

Manish Shah, M.D., gastrointestinal oncology expert at the Meyer Cancer Center of Weill Cornell Medicine

2017 Aug 18

Exploring the decreasing incidence of colon cancer in those over the age of 50

Manish A. Shah, M.D., discusses the decreasing incidence of colon cancer diagnosis in those over the age of 50. Read more

2017 Aug 15

Considering factors for upfront therapy in CLL

Richard R. Furman, M.D., discusses factors to consider when choosing upfront therapy for patients with chronic lymphocytic leukemia (CLL). Read more

2017 Aug 10

Inside NYP: Chief Resident Dr. Babacar Cisse

Profile of Babacar Cisse, M.D., Ph.D., a new assistant professor of neurosurgery who came to America with $26 in his pocket and achieved his dream of becoming a doctor. Read more

2017 Aug 09

Lung cancer: How to protect yourself from blood clots

Maria De Sancho, M.D., discusses the increased risk of deep vein thrombosis among cancer patients. Read more

2017 Aug 08

ASCT-related toxicities for patients with MCL

Peter Martin, M.D., discusses the toxicities related to stem cell transplantation for patients with mantle cell lymphoma (MCL). Read more

2017 Aug 08

Spotlight on Staff: Meet Dr. Ana Patricia Da Silva Gomes

Profile of postdoctoral researcher Ana Patricia Da Silva Gomes, Ph.D. Read more

2017 Aug 07

Patient selection for immunotherapy in gastric cancer

Manish A. Shah, M.D., joins a panel to discuss immunotherapy treatment for gastric cancer. Read more

2017 Aug 07

Exciting advancements in the field of mantle cell lymphoma

John P. Leonard, M.D., professor of medicine, discusses some of the exciting advancements taking place in the field of mantle cell lymphoma (MCL). Read more

2017 Aug 04

Sequencing therapies for patients with multiple myeloma

Ruben Niesvizky, M.D. discusses sequencing agents for patients with multiple myeloma. Read more

2017 Aug 04

Challenges with CAR T-cell therapy in ALL

Gail Roboz, M.D., discusses the challenges clinicians are facing with chimeric antigen receptor (CAR) T-cell therapy in acute lymphoblastic leukemia (ALL). Read more

2017 Aug 03

Second-generation BTK inhibitors in CLL

Richard R. Furman, M.D., discusses second-generation BTK inhibitors, such as acalabrutinib and BGB-3111 in chronic lymphocytic leukemia (CLL). Read more

2017 Aug 02

Skip the Bone Marrow Biopsy in Follicular Lymphoma?

Clinical trials in patients with follicular lymphoma (FL) mandate that patients undergo bone marrow biopsies (BMBs) at baseline and at subsequent points following treatment in order to monitor response, but the biopsies are unnecessary in most patients, argues Sarah Rutherford, M.D., and colleagues. Read more